GEMCITABINE for Diffuse large b-cell lymphoma recurrent: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 117 adverse event reports in the FDA FAERS database where GEMCITABINE was used for Diffuse large b-cell lymphoma recurrent.
Most Reported Side Effects for GEMCITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 3,319 | 10.6% | 496 | 1,162 |
| Disease progression | 3,123 | 10.0% | 558 | 411 |
| Thrombocytopenia | 2,320 | 7.4% | 271 | 875 |
| Drug ineffective | 2,003 | 6.4% | 486 | 431 |
| Malignant neoplasm progression | 1,962 | 6.3% | 602 | 411 |
| Neutropenia | 1,892 | 6.0% | 235 | 512 |
| Anaemia | 1,745 | 5.6% | 223 | 820 |
| Pyrexia | 1,511 | 4.8% | 148 | 1,102 |
| Nausea | 1,336 | 4.3% | 146 | 650 |
| Myelosuppression | 1,197 | 3.8% | 50 | 559 |
| Fatigue | 1,098 | 3.5% | 124 | 440 |
| Febrile neutropenia | 1,082 | 3.5% | 264 | 653 |
| Diarrhoea | 1,074 | 3.4% | 179 | 603 |
| Vomiting | 1,016 | 3.2% | 116 | 645 |
| Neoplasm progression | 960 | 3.1% | 239 | 175 |
Other Indications for GEMCITABINE
Pancreatic carcinoma (2,706)
Diffuse large b-cell lymphoma (2,506)
Product used for unknown indication (2,401)
Pancreatic carcinoma metastatic (1,586)
Cholangiocarcinoma (1,181)
Adenocarcinoma pancreas (1,089)
Bladder cancer (841)
Transitional cell carcinoma (825)
Ovarian cancer (648)
Non-small cell lung cancer (634)
Other Drugs Used for Diffuse large b-cell lymphoma recurrent
RITUXIMAB (507)
ETOPOSIDE (174)
BENDAMUSTINE (168)
CYTARABINE (165)
DEXAMETHASONE (162)
CYCLOPHOSPHAMIDE (144)
CISPLATIN (137)
AXICABTAGENE CILOLEUCEL (123)
TISAGENLECLEUCEL (118)
VINCRISTINE (108)